Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M A Polis

Showing results (31-40 of 71) with videos related to

Pageof 8
Sort By:
Journal of Clinical Immunology|May 11, 1992
Indeterminate western blot patterns in a cohort of individuals at high risk for human immunodeficiency virus (HIV-1) exposureR T Davey, L R Deyton, J A Metcalf, et al.
The Journal of Clinical Investigation|August 1, 1993
Induction of humoral and cell-mediated anti-human immunodeficiency virus (HIV) responses in HIV sero-negative volunteers by immunization with recombinant gp160J A Kovacs, M B Vasudevachari, M Easter, et al.
The American Journal of Medicine|February 1, 1993
Increased survival of a cohort of patients with acquired immunodeficiency syndrome and cytomegalovirus retinitis who received sodium phosphonoformate (foscarnet)M A Polis, M D deSmet, B F Baird, et al.
The Journal of Infectious Diseases|November 1, 1994
Use of recombinant soluble CD4 Pseudomonas exotoxin, a novel immunotoxin, for treatment of persons infected with human immunodeficiency virusR T Davey, C M Boenning, B R Herpin, et al.
Antimicrobial Agents and Chemotherapy|June 1, 1995
Clinical pharmacokinetics of cidofovir in human immunodeficiency virus-infected patientsK C Cundy, B G Petty, J Flaherty, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 15, 1993
Plasma viremia as a sensitive indicator of the antiretroviral activity of L-697,661R T Davey, R L Dewar, G F Reed, et al.
The Journal of Infectious Diseases|July 11, 1991
A phase I/II trial of zidovudine, interferon-alpha, and granulocyte-macrophage colony-stimulating factor in the treatment of human immunodeficiency virus type 1 infectionR T Davey, V J Davey, J A Metcalf, et al.
Annals of Internal Medicine|June 1, 1988
Loss of human immunodeficiency virus type 1 (HIV-1) antibodies with evidence of viral infection in asymptomatic homosexual men. A report from the Multicenter AIDS Cohort StudyH Farzadegan, M A Polis, S M Wolinsky, et al.
Annals of Internal Medicine|November 1, 1991
A randomized, controlled trial of foscarnet in the treatment of cytomegalovirus retinitis in patients with AIDSA G Palestine, M A Polis, M D De Smet, et al.
The New England Journal of Medicine|March 2, 1995
Increases in CD4 T lymphocytes with intermittent courses of interleukin-2 in patients with human immunodeficiency virus infection. A preliminary studyJ A Kovacs, M Baseler, R J Dewar, et al.
Pageof 8

Showing results (31-40 of 71) with videos related to

Sort By:
Pageof 8
Journal of Clinical Immunology|May 11, 1992
Indeterminate western blot patterns in a cohort of individuals at high risk for human immunodeficiency virus (HIV-1) exposureR T Davey, L R Deyton, J A Metcalf, et al.
The Journal of Clinical Investigation|August 1, 1993
Induction of humoral and cell-mediated anti-human immunodeficiency virus (HIV) responses in HIV sero-negative volunteers by immunization with recombinant gp160J A Kovacs, M B Vasudevachari, M Easter, et al.
The American Journal of Medicine|February 1, 1993
Increased survival of a cohort of patients with acquired immunodeficiency syndrome and cytomegalovirus retinitis who received sodium phosphonoformate (foscarnet)M A Polis, M D deSmet, B F Baird, et al.
The Journal of Infectious Diseases|November 1, 1994
Use of recombinant soluble CD4 Pseudomonas exotoxin, a novel immunotoxin, for treatment of persons infected with human immunodeficiency virusR T Davey, C M Boenning, B R Herpin, et al.
Antimicrobial Agents and Chemotherapy|June 1, 1995
Clinical pharmacokinetics of cidofovir in human immunodeficiency virus-infected patientsK C Cundy, B G Petty, J Flaherty, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 15, 1993
Plasma viremia as a sensitive indicator of the antiretroviral activity of L-697,661R T Davey, R L Dewar, G F Reed, et al.
The Journal of Infectious Diseases|July 11, 1991
A phase I/II trial of zidovudine, interferon-alpha, and granulocyte-macrophage colony-stimulating factor in the treatment of human immunodeficiency virus type 1 infectionR T Davey, V J Davey, J A Metcalf, et al.
Annals of Internal Medicine|June 1, 1988
Loss of human immunodeficiency virus type 1 (HIV-1) antibodies with evidence of viral infection in asymptomatic homosexual men. A report from the Multicenter AIDS Cohort StudyH Farzadegan, M A Polis, S M Wolinsky, et al.
Annals of Internal Medicine|November 1, 1991
A randomized, controlled trial of foscarnet in the treatment of cytomegalovirus retinitis in patients with AIDSA G Palestine, M A Polis, M D De Smet, et al.
The New England Journal of Medicine|March 2, 1995
Increases in CD4 T lymphocytes with intermittent courses of interleukin-2 in patients with human immunodeficiency virus infection. A preliminary studyJ A Kovacs, M Baseler, R J Dewar, et al.
Pageof 8